Christensen Jamie 4
4 · Mirati Therapeutics, Inc. · Filed Jan 5, 2024
Insider Transaction Report
Form 4
Christensen Jamie
SVP & Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-01-04$58.81/sh−1,531$90,038→ 157,135 total
Footnotes (1)
- [F1]Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 3, 2020.